Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Science (New York, N.Y.)|October 16, 1999
Pharmacogenomics: translating functional genomics into rational therapeuticsW E Evans, M V Relling
Arizona Medicine|August 1, 1983
Choosing a sunscreenM V Relling, R T Dorr
Molecular Pharmacology|May 1, 1990
Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family studyW E Evans, M V Relling
American Journal of Hospital Pharmacy|November 1, 1992
Stability of etoposide solution for oral useH L McLeod, M V Relling
Clinical Pharmacokinetics|October 1, 1994
Clinical pharmacokinetics of paclitaxelD S Sonnichsen, M V Relling
Pharmacogenetics|December 1, 1991
Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizersW E Evans, M V Relling
Journal of Chromatography|July 1, 1992
Automated high-performance liquid chromatographic assay for the determination of 7-ethoxycoumarin and umbelliferoneR R Evans, M V Relling
Pharmacogenetics|April 1, 1996
Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksC L Chen, Q Liu, M V Relling
Clinical Pharmacology and Therapeutics|July 27, 2017
Response to "PNPLA3 rs738409 and Hepatotoxicity in Children With B-cell Acute Lymphoblastic Leukemia: A Validation Study in a Spanish Cohort"Y Liu, C A Fernandez, M V Relling
Leukemia|April 22, 2005
MLL methylation is not likely a common mechanism for therapy-related AMLA Bogni, C-H Pui, M V Relling
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Science (New York, N.Y.)|October 16, 1999
Pharmacogenomics: translating functional genomics into rational therapeuticsW E Evans, M V Relling
Arizona Medicine|August 1, 1983
Choosing a sunscreenM V Relling, R T Dorr
Molecular Pharmacology|May 1, 1990
Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family studyW E Evans, M V Relling
American Journal of Hospital Pharmacy|November 1, 1992
Stability of etoposide solution for oral useH L McLeod, M V Relling
Clinical Pharmacokinetics|October 1, 1994
Clinical pharmacokinetics of paclitaxelD S Sonnichsen, M V Relling
Pharmacogenetics|December 1, 1991
Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizersW E Evans, M V Relling
Journal of Chromatography|July 1, 1992
Automated high-performance liquid chromatographic assay for the determination of 7-ethoxycoumarin and umbelliferoneR R Evans, M V Relling
Pharmacogenetics|April 1, 1996
Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksC L Chen, Q Liu, M V Relling
Clinical Pharmacology and Therapeutics|July 27, 2017
Response to "PNPLA3 rs738409 and Hepatotoxicity in Children With B-cell Acute Lymphoblastic Leukemia: A Validation Study in a Spanish Cohort"Y Liu, C A Fernandez, M V Relling
Leukemia|April 22, 2005
MLL methylation is not likely a common mechanism for therapy-related AMLA Bogni, C-H Pui, M V Relling
Pageof 18